First polymer-based meniscus implant granted expedited review by FDA - Plastics Today

First polymer-based meniscus implant granted expedited review by FDA  Plastics Today

The first “artificial” meniscus implant made of a medical-grade polymer to be marketed in Europe has been granted a Breakthrough Device Designation by FDA.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more